62 related articles for article (PubMed ID: 23538625)
1. Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure.
Alió JL; Mulet ME; Haroun H; Merayo J; Ruiz Moreno JM
Br J Ophthalmol; 2004 Dec; 88(12):1585-9. PubMed ID: 15550368
[TBL] [Abstract][Full Text] [Related]
2. The first-in-human implantation of the CorNeat keratoprosthesis.
Bahar I; Reitblat O; Livny E; Litvin G
Eye (Lond); 2023 May; 37(7):1331-1335. PubMed ID: 35650323
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom.
Williams GP; Radford C; Nightingale P; Dart JK; Rauz S
Eye (Lond); 2011 Sep; 25(9):1207-18. PubMed ID: 21799523
[TBL] [Abstract][Full Text] [Related]
4. Ocular Mucous Membrane Pemphigoid: The Effect of Risk Factors at Presentation on Treatment Outcomes.
Ruiz-Lozano RE; Colorado-Zavala MF; Ramos-Dávila EM; Quiroga-Garza ME; Azar NS; Mousa HM; Hernández-Camarena JC; Stinnett SS; Daluvoy M; Kim T; Sainz-de-la-Maza M; Hall RP; Rodriguez-Garcia A; Perez VL
Ophthalmology; 2024 Mar; ():. PubMed ID: 38452874
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine 0.1% (Ikervis
Rahhal-Ortuño M; Fernández-Santodomingo AS; Villena-Alvarado C; Marín-Payá E; Aguilar-González M; García-Delpech S
Taiwan J Ophthalmol; 2020; 10(4):309-311. PubMed ID: 33437608
[TBL] [Abstract][Full Text] [Related]
6. Boston Keratoprosthesis: expanding the boundaries.
Harissi-Dagher M
Digit J Ophthalmol; 2011; 17(4):53-4. PubMed ID: 23362398
[No Abstract] [Full Text] [Related]
7. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Boston Keratoprosthesis Type I Implantation in Poland: A Retrospective Study on 118 Patients.
Wróblewska-Czajka E; Dobrowolski D; Wylęgała A; Jurkunas UV; Wylęgała E
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398288
[No Abstract] [Full Text] [Related]
9. Application of biomaterials and nanotechnology in corneal tissue engineering.
Soleimani M; Ebrahimi Z; Ebrahimi KS; Farhadian N; Shahlaei M; Cheraqpour K; Ghasemi H; Moradi S; Chang AY; Sharifi S; Baharnoori SM; Djalilian AR
J Int Med Res; 2023 Jul; 51(7):3000605231190473. PubMed ID: 37523589
[TBL] [Abstract][Full Text] [Related]
10. Keratoprosthesis in dry eye disease.
Sharma S; Donthineni PR; Iyer G; Chodosh J; de la Paz MF; Maskati Q; Srinivasan B; Agarwal S; Basu S; Shanbhag SS
Indian J Ophthalmol; 2023 Apr; 71(4):1154-1166. PubMed ID: 37026247
[TBL] [Abstract][Full Text] [Related]
11. Artificial Cornea: Past, Current, and Future Directions.
Holland G; Pandit A; Sánchez-Abella L; Haiek A; Loinaz I; Dupin D; Gonzalez M; Larra E; Bidaguren A; Lagali N; Moloney EB; Ritter T
Front Med (Lausanne); 2021; 8():770780. PubMed ID: 34869489
[TBL] [Abstract][Full Text] [Related]
12. Boston Type 1 Keratoprosthesis: Updated Perspectives.
Nonpassopon M; Niparugs M; Cortina MS
Clin Ophthalmol; 2020; 14():1189-1200. PubMed ID: 32425503
[TBL] [Abstract][Full Text] [Related]
13. Ocular Manifestations and Management of Autoimmune Bullous Diseases.
Feizi S; Roshandel D
J Ophthalmic Vis Res; 2019; 14(2):195-210. PubMed ID: 31114657
[TBL] [Abstract][Full Text] [Related]
14. Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients.
Robert MC; Arafat SN; Ciolino JB
Eye Contact Lens; 2014 Nov; 40(6):376-81. PubMed ID: 25320957
[TBL] [Abstract][Full Text] [Related]
15. UV cross-linking of donor corneas confers resistance to keratolysis.
Arafat SN; Robert MC; Shukla AN; Dohlman CH; Chodosh J; Ciolino JB
Cornea; 2014 Sep; 33(9):955-9. PubMed ID: 25014151
[TBL] [Abstract][Full Text] [Related]
16. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
Palioura S; Kim B; Dohlman CH; Chodosh J
Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625
[TBL] [Abstract][Full Text] [Related]
17. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
18. The Boston keratoprosthesis in Stevens-Johnson syndrome.
Sayegh RR; Ang LP; Foster CS; Dohlman CH
Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
[TBL] [Abstract][Full Text] [Related]
19. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
